Longwall Ventures invests in innovative, UK based, early stage companies in the healthcare, science and engineering sectors
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 2
| Date | Name | Website | Total Raised | Location |
| 15.04.2026 | Lightcast | lightcast.bio | $76M | United Kin... |
| 17.04.2023 | Caristo Di... | caristo.com | $16.3M | United Kin... |
Mentions in press and media 17
| Date | Title | Description |
| 22.05.2026 | Cambridge Wide Open Week 2026 announces top-tier keynotes & participating ventures for new expanded format | Cambridge Wide Open Week 2026 has unveiled further details of its highly anticipated June 11–19 event as the life sciences festival expands across the UK’s innovation “Golden Triangle” for the very first time. Keynote speakers for the event... |
| 21.04.2026 | Lightcast Secures Major Funding, Redefines Single-Cell Analysis with Envisia Platform | Lightcast, a life science innovator, secured $27 million in funding. ARCH Venture Partners led the round. This capital fuels the 2026 commercial launch of its Envisia™ benchtop platform. Envisia marks a significant leap in single-cell analy... |
| 15.04.2026 | Lightcast Raises $27M in Funding | Lightcast, a Cambridge, UK-based life science tools company focused on functional single-cell analysis, raised $27M in funding. The round was led by ARCH Venture Partners with participation from M Ventures, Illumina Ventures, +ND Capital, L... |
| 14.04.2026 | Lightcast Raises $27 Million and Adds Industry Veteran to Accelerate Commercialization of Envisia™ Platform | · Proceeds will help enhance workflows and expand single-cell functional assay portfolio · Brad Crutchfield joins as advisor to support early access growth and global launch CAMBRIDGE, England – April 14, 2026 – Lightcast, a pioneering life... |
| 25.08.2025 | Oxford-based OrganOx achieves one of the UK’s largest medtech exits at $1.5 billion valuation | OrganOx, an Oxford-based medtech company that developed technology to preserve donor livers outside the human body, has been acquired in a deal valued at $1.5 billion. This marks one of the UK’s largest medtech exits and delivers £175 milli... |
| 25.08.2025 | OrganOx achieves one of the UK’s largest medtech exit to date | OrganOx, the Oxford-based medtech company behind pioneering liver perfusion technology that has transformed transplant outcomes worldwide, has been acquired in a deal valued at approximately $1.5 billion. The transaction also delivered BGF’... |
| 24.02.2025 | OrganOx Closes $142M Equity Financing | OrganOx, an Oxford, UK-based organ medical technology company, raised $142M in equity funding. The round was led by new investor HealthQuest Capital with participation from existing investors BGF and Lauxera Capital Partners, along with add... |
| 06.04.2024 | Biofidelity Secures €22M in Funding: A Game-Changer in Genomic Technology | Cambridge-based Biofidelity, a genomic technology company, has just locked in a hefty €22M in funding, propelling its total funding to a staggering €55.3M. This cash injection, led by key investors like Octopus Ventures and Agilent Technolo... |
| 03.04.2024 | Biofidelity Raises $24M in Funding | Biofidelity, a Cambridge, UK- and Morrisville, NC-based genomic technology company, raised $24M in funding. Backers included Agilent Technologies, Octopus Ventures, BlueYard Capital, and Longwall Ventures. Led by Dr. Barnaby Balmforth, CEO,... |
| 28.04.2023 | Wayland Additive – raises £4.6m in latest funding round | We are delighted to announce our latest investment into Wayland Additive, as part of a £4.6m funding round. This latest investment will increase Wayland’s in-house production capability delivering more machines and materials to its customer... |
Show more